MPV17L can protect against mitochondrial oxidative stress and apoptosis by activation of Omi/HtrA2 protease, and its methylation has been shown to be associated with the prognosis of lung adenocarcinoma. The gene discussed is HTRA2; the disease is lung adenocarcinoma.